About CCSB
|
News
|
Contact Us
|
Site Map
中文版
ESG
Investor Relations
Events
Contract Research
Contract Manufacturing
API Products
News
Download
News
Home
>
News
> News
2022/05/10
CCSB accomplished Caspofungin and Trandolapril remote audit.
5/10 CCSB accomplished Caspofungin and Trandolapril remote audit, client from Greece.
CCSB accomplished an inspection of Taiwan Food and Drug Administration (TFDA).
Obtained Outstanding Company of the year, 2022 Taiwan BIO awards